niner

I am a PennyStocking Silver member!! O.K. so more about myself. I have been studying about 5 years, I have been doing some trading on my own. I also, have been discovering technics on my own. I have won more on bluechip stocks than pennystocks. Overall I am probably down $350. I have made other comments about my past losers and winners. To get fully upto speed-I have won on $AMD in at $11.40 out at $12.98 with 52 shares a gain of $62.45. I loss at APTO in at $1.32 and out at $1.13 on 496 shares a loss of $94.24 $MSFT is such a small winner at $1.06 $RIGL was a big losser for me I had this one long term, in at $3.54 and sold at $2.74 with a loss of $50.37 4.4.17 I was not comfortable going to big today, so I already had one on my watchlist... ZENO in at $1.47 out at $1.67 with 482 shares with a gain of $82.48 I am currently holding SHOP, SNAP and BSGM

Join now or log in to leave a comment
osirustwits

[TimAlerts] EGLT $TDW $$CIE all swings which could be a week or longer. $PIP for the special divvy been in over a month long term account 90% of my account is in that also $PIP puts for insurance $DRYS have my lottery shares (40) $RIGL calls for March 2017 that is all I have in my personal accounts

osirustwits

[TimAlerts] I covered all shorts on shippers $DSX $SINO sold puts on $DSX also and flat on ever thing but my $DB calls and $RIGL calls roughly $4600 for the day 66 trades including scaling out green on every name but $RCON $12 loss

Received 6 Karmas
WaveRacer

[TimChallenge] hey turbobob any thoughts on $RIGL ? got in on panic dip bounce at 2.36 this morning now holding o/n, shot up to 2.90s before heavy selling back down to 2.70s at close...close reading shows the "bad news" may not have been so bad...somewhat bullish back to the 3s IMO, shareholders believe in the drug and they're taking it to FDA

osirustwits

[TimAlerts] $RIGL the reason is the delta if this stock ever hits $3 before end of the year I could make 70% calls were under valued

steven607

[TimAlerts] $RIGL shares dropped 32 percent to $2.19 after the company reported results from the second FIT Phase 3 study for fostamatinib. The company disclosed that the study did not meet primary endpoint.

osirustwits

[TimAlerts] $RIGL closed my second short I have issues charting and no time and sales short 1st time $2.45 add $2.30 covered 1/2 $2 1/4 $1.90 round 2 short $2.20 covered $2.02

Page
of 36